atropine has been researched along with sb 271046 in 1 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (sb 271046) | Trials (sb 271046) | Recent Studies (post-2010) (sb 271046) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 71 | 0 | 24 |
Protein | Taxonomy | atropine (IC50) | sb 271046 (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.002 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dawson, LA; Li, P; Nguyen, HQ | 1 |
1 other study(ies) available for atropine and sb 271046
Article | Year |
---|---|
The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus.
Topics: Animals; Atropine; Dopamine; Excitatory Amino Acids; Extracellular Space; Glutamic Acid; Hippocampus; Male; Microdialysis; Muscarinic Antagonists; Norepinephrine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Sulfonamides; Synaptic Transmission; Tetrodotoxin; Thiophenes | 2001 |